Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer
Clinical trial NCT04722978 · RECRUITING
Trial details
- NCT number
- NCT04722978
- Sponsor
- Sun Yat-Sen University Cancer Center
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-20
- Primary completion
- 2026-06-01
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.